tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Technical Analysis

28 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Conduit Pharmaceuticals’s (CDT) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Conduit Pharmaceuticals is a Buy.
Conduit Pharmaceuticals’s (CDT) 20-Day exponential moving average is 3.06, while Conduit Pharmaceuticals’s (CDT) share price is $2.97, making it a Sell.
Conduit Pharmaceuticals’s (CDT) 50-Day exponential moving average is 3.15, while Conduit Pharmaceuticals’s (CDT) share price is $2.97, making it a Sell.

Conduit Pharmaceuticals (CDT) Pivot Points

May 16, 2024, 03:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.80
2.88
2.98
3.06
3.16
3.24
3.34
Fibonacci
2.88
2.95
2.99
3.06
3.12
3.17
3.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Conduit Pharmaceuticals (CDT) Moving Averages

May 16, 2024, 03:40 AM
Period
Simple
Exponential
MA5
2.98Sell
2.98Sell
MA10
3.00Sell
3.01Sell
MA20
3.06Sell
3.06Sell
MA50
3.17Sell
3.15Sell
MA100
3.33Sell
3.53Sell
MA200
4.81Sell
5.30Sell
Conduit Pharmaceuticals’s (CDT) 10-Day exponential moving average is 3.01, while Conduit Pharmaceuticals’s (CDT) share price is $2.97, making it a Sell.
Conduit Pharmaceuticals’s (CDT) 100-Day exponential moving average is 3.53, while Conduit Pharmaceuticals’s (CDT) share price is $2.97, making it a Sell.
Conduit Pharmaceuticals’s (CDT) stock price is $2.97 and Conduit Pharmaceuticals’s (CDT) 50-day simple moving average is 3.17, creating a Sell signal.
Conduit Pharmaceuticals’s (CDT) stock price is $2.97 and Conduit Pharmaceuticals’s (CDT) 100-day simple moving average is 3.33, creating a Sell signal.
Conduit Pharmaceuticals’s (CDT) stock price is $2.97 and Conduit Pharmaceuticals’s (CDT) 200-day simple moving average is 4.81, creating a Sell signal.

Conduit Pharmaceuticals (CDT) Technical Indicators

May 16, 2024, 03:40 AM
Name
Value
Implied Action
RSI (14)
42.75
Neutral
STOCH (9,6)
22.49
Neutral
STOCHRSI (14)
22.49
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
11.56
Buy
Williams %R
-94.29
Buy
CCI (14)
-164.39
Buy
ATR (14)
0.28
-
Ultimate Oscillator
30.91
Neutral
ROC
-10.69
Sell
Conduit Pharmaceuticals’s (CDT) Relative Strength Index (RSI) is 42.75, creating a Neutral signal.
Conduit Pharmaceuticals’s (CDT) Trend Strength Indicator (ADX) is 11.56, creating a Buy signal.
Conduit Pharmaceuticals’s (CDT) Commodity Channel Index (CCI) is -164.39, creating a Buy signal.
Conduit Pharmaceuticals’s (CDT) Price Rate of Change (ROC) is -10.69, creating a Sell signal.

FAQ

Is CDT a Buy, Hold, or Sell?
Based on CDT’s technical indicators, CDT is a Sell.
    What is CDT’s RSI (14)?
    CDT’s RSI (14) is 42.75, which suggests CDT is a Neutral.
      What is CDT’s MACD?
      CDT’s MACD is -0.06, which suggests CDT is a Buy.
        What is CDT’s 5-day moving average?
        CDT’s 5-day moving average is 2.98, which suggests CDT is a Sell.
          What is CDT’s 20-day moving average?
          CDT 20-day moving average is 3.06, which suggests CDT is a Sell.
            What is CDT’s 50-day moving average?
            CDT’s 50-day moving average is 3.17, which suggests CDT is a Sell.
              What is CDT’s 200-day moving average?
              CDT’s 200-day moving average is 4.81, which suggests CDT is a Sell.
                What is CDT’s Williams % R (14)?
                CDT’s Williams % R (14) is -94.29, which suggests CDT is a Buy.
                  What is CDT’s CCI (14)?
                  CDT’s CCI (14) is -164.39, which suggests CDT is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis